Ligand Pharmaceuticals Statistics
Total Valuation
CRD.A has a market cap or net worth of $453.68 million. The enterprise value is $703.09 million.
| Market Cap | 453.68M |
| Enterprise Value | 703.09M |
Important Dates
The last earnings date was Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
CRD.A has 30.50 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 30.50M |
| Shares Outstanding | 30.50M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 21.47M |
Valuation Ratios
The trailing PE ratio is 15.31 and the forward PE ratio is 9.17.
| PE Ratio | 15.31 |
| Forward PE | 9.17 |
| PS Ratio | 0.35 |
| Forward PS | 0.31 |
| PB Ratio | 2.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.15 |
| P/OCF Ratio | 5.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.72, with an EV/FCF ratio of 9.53.
| EV / Earnings | 23.72 |
| EV / Sales | 0.54 |
| EV / EBITDA | 8.72 |
| EV / EBIT | 11.18 |
| EV / FCF | 9.53 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 1.77.
| Current Ratio | 1.34 |
| Quick Ratio | 1.23 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | 2.63 |
| Debt / FCF | 4.20 |
| Interest Coverage | 3.12 |
Financial Efficiency
Return on equity (ROE) is 18.34% and return on invested capital (ROIC) is 8.16%.
| Return on Equity (ROE) | 18.34% |
| Return on Assets (ROA) | 4.96% |
| Return on Invested Capital (ROIC) | 8.16% |
| Return on Capital Employed (ROCE) | 12.14% |
| Revenue Per Employee | $130,643 |
| Profits Per Employee | $2,952 |
| Employee Count | 10,040 |
| Asset Turnover | 1.65 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRD.A has paid $17.38 million in taxes.
| Income Tax | 17.38M |
| Effective Tax Rate | 36.82% |
Stock Price Statistics
The stock price has decreased by -2.56% in the last 52 weeks. The beta is 0.77, so CRD.A's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -2.56% |
| 50-Day Moving Average | 10.47 |
| 200-Day Moving Average | 11.15 |
| Relative Strength Index (RSI) | 28.27 |
| Average Volume (20 Days) | 42,816 |
Short Selling Information
The latest short interest is 300,716, so 0.99% of the outstanding shares have been sold short.
| Short Interest | 300,716 |
| Short Previous Month | 272,857 |
| Short % of Shares Out | 0.99% |
| Short % of Float | 1.40% |
| Short Ratio (days to cover) | 5.15 |
Income Statement
In the last 12 months, CRD.A had revenue of $1.31 billion and earned $29.64 million in profits. Earnings per share was $0.59.
| Revenue | 1.31B |
| Gross Profit | 376.73M |
| Operating Income | 62.90M |
| Pretax Income | 35.08M |
| Net Income | 29.64M |
| EBITDA | 80.59M |
| EBIT | 62.90M |
| Earnings Per Share (EPS) | $0.59 |
Balance Sheet
The company has $58.53 million in cash and $309.49 million in debt, giving a net cash position of -$250.96 million or -$8.23 per share.
| Cash & Cash Equivalents | 58.53M |
| Total Debt | 309.49M |
| Net Cash | -250.96M |
| Net Cash Per Share | -$8.23 |
| Equity (Book Value) | 175.34M |
| Book Value Per Share | 3.58 |
| Working Capital | 95.06M |
Cash Flow
In the last 12 months, operating cash flow was $80.96 million and capital expenditures -$7.19 million, giving a free cash flow of $73.76 million.
| Operating Cash Flow | 80.96M |
| Capital Expenditures | -7.19M |
| Free Cash Flow | 73.76M |
| FCF Per Share | $2.42 |
Margins
Gross margin is 28.72%, with operating and profit margins of 4.80% and 2.26%.
| Gross Margin | 28.72% |
| Operating Margin | 4.80% |
| Pretax Margin | 3.60% |
| Profit Margin | 2.26% |
| EBITDA Margin | 6.14% |
| EBIT Margin | 4.80% |
| FCF Margin | 5.62% |
Dividends & Yields
This stock pays an annual dividend of $0.29, which amounts to a dividend yield of 3.13%.
| Dividend Per Share | $0.29 |
| Dividend Yield | 3.13% |
| Dividend Growth (YoY) | 1.79% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 47.92% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 3.02% |
| Earnings Yield | 6.53% |
| FCF Yield | 16.26% |
Analyst Forecast
The average price target for CRD.A is $14.00, which is 53.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 53.51% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 26, 1997. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 26, 1997 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
CRD.A has an Altman Z-Score of 2.98 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 7 |